Incretin dysregulation of lysyl oxidase: a new mechanism for diabetic bone disease
The American Diabetes Association has determined that the number of people with diabetes in America was 30.3 million in 2015, and it is becoming increasingly more prevalent. Diabetes is a condition characterized by chronic hyperglycemia due to either insufficient insulin or reduced insulin sensitivi...
Main Author: | Shrestha, Neha |
---|---|
Other Authors: | Trackman, Philip |
Language: | en_US |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/33035 |
Similar Items
-
Incretin dysregulation of lysyl oxidase: a novel mechanism for diabetic osteopenia
by: Daley, Eileen
Published: (2019) -
Bone phenotype of lysyl oxidase isoform knockout mice & in vitro expression of lysyl oxidase proenzyme
by: Alsofi, Loai A.
Published: (2018) -
Bone phenotype of lysyl oxidase isoform knockout mice & in vitro expression of lysyl oxidase proenzyme (II)
by: Alsofi, Loai Abdulfattah M.
Published: (2018) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-like Proteins
by: Sylvain D. Vallet, et al.
Published: (2021-12-01) -
Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus
by: Eileen J Daley, et al.
Published: (2019-10-01)